Kempiak S - Search Results

1

Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin.

Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M, Segall J, Eddy R, Miki H, Takenawa T, Condeelis J. Yamaguchi H, et al. Among authors: kempiak s. J Cell Biol. 2005 Jan 31;168(3):441-52. doi: 10.1083/jcb.200407076. J Cell Biol. 2005. PMID: 15684033 Free PMC article.

2

Local signaling by the EGF receptor.

Kempiak SJ, Yip SC, Backer JM, Segall JE. Kempiak SJ, et al. J Cell Biol. 2003 Sep 1;162(5):781-7. doi: 10.1083/jcb.200303144. J Cell Biol. 2003. PMID: 12952932 Free PMC article.

3

A neural Wiskott-Aldrich Syndrome protein-mediated pathway for localized activation of actin polymerization that is regulated by cortactin.

Kempiak SJ, Yamaguchi H, Sarmiento C, Sidani M, Ghosh M, Eddy RJ, Desmarais V, Way M, Condeelis J, Segall JE. Kempiak SJ, et al. J Biol Chem. 2005 Feb 18;280(7):5836-42. doi: 10.1074/jbc.M410713200. Epub 2004 Dec 4. J Biol Chem. 2005. PMID: 15579908 Free article.

4

Stimulation of cells using EGF-coated magnetic beads.

Kempiak SJ, Segall JE. Kempiak SJ, et al. Sci STKE. 2004 Jan 27;2004(218):pl1. doi: 10.1126/stke.2182004pl1. Sci STKE. 2004. PMID: 14762217

5

Validation and comparison of quality-of-life measures for topical 5-fluorouracil treatment: results from a randomized controlled trial.

Pomerantz H, Chren MM, Lew R, Weinstock MA; VA Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial Group*. Pomerantz H, et al. Clin Exp Dermatol. 2017 Jul;42(5):488-495. doi: 10.1111/ced.13089. Clin Exp Dermatol. 2017. PMID: 28621489 Clinical Trial.

6

Correlates of skin-related quality of life (QoL) in those with multiple keratinocyte carcinomas (KCs): A cross-sectional study.

Siegel JA, Chren MM, Weinstock MA; Department of Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial Group. Siegel JA, et al. J Am Acad Dermatol. 2016 Sep;75(3):639-642. doi: 10.1016/j.jaad.2016.05.008. J Am Acad Dermatol. 2016. PMID: 27543222 No abstract available.

7

Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.

Pomerantz H, Hogan D, Eilers D, Swetter SM, Chen SC, Jacob SE, Warshaw EM, Stricklin G, Dellavalle RP, Sidhu-Malik N, Konnikov N, Werth VP, Keri J, Lew R, Weinstock MA; Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial Group. Pomerantz H, et al. JAMA Dermatol. 2015 Sep;151(9):952-60. doi: 10.1001/jamadermatol.2015.0502. JAMA Dermatol. 2015. PMID: 25950503 Clinical Trial.

8

Measuring the severity of topical 5-fluorouracil toxicity.

Korgavkar K, Firoz EF, Xiong M, Lew R, Marcolivio K, Burnside N, Dyer R, Weinstock MA; VAKCC Trial Group. Korgavkar K, et al. J Cutan Med Surg. 2014 Jul-Aug;18(4):229-35. doi: 10.2310/7750.2013.13143. J Cutan Med Surg. 2014. PMID: 25008439 Clinical Trial.

9

What is your diagnosis? The diagnosis: Kaposi varicelliform eruption (Eczema herpeticum).

Breithaupt AD, Di Nardo A, Kempiak SJ. Breithaupt AD, et al. Among authors: kempiak sj. Cutis. 2012 Jul;90(1):13, 24-5. Cutis. 2012. PMID: 22908727 No abstract available.

10

Sea urchin granuloma secondary to Strongylocentrotus purpuratus and Strongylocentrotus franciscanus.

Kabigting FD, Kempiak SJ, Alexandrescu DT, Yu BD. Kabigting FD, et al. Among authors: kempiak sj. Dermatol Online J. 2009 May 15;15(5):9. Dermatol Online J. 2009. PMID: 19624987 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters